# Predictive Factors of Clinical Response to Ustekinumab in Active Crohn's Disease

> **NCT03351647** · — · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 18 (actual)

## Conditions studied

- Crohn Disease

## Interventions

- **BIOLOGICAL:** Evaluation of biological predictive factors of clinical response to ustekinumab

## Key facts

- **NCT ID:** NCT03351647
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-14
- **Primary completion:** 2018-08-29
- **Final completion:** 2019-09-23
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2022-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03351647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03351647, "Predictive Factors of Clinical Response to Ustekinumab in Active Crohn's Disease". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03351647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*